LBx Bio

Revolutionizing Cancer Detection

We've developed a liquid biopsy platform capable of detecting cancer using Artificial Intelligence (AI) and Machine Learning (ML) to interpret signals from DNA- and RNA-based biomarkers

Early Cancer Detection

Improve patient outcomes and increase the chances of successful treatment and reducing mortality.

Companion Diagnostics

Guiding treatment selection and monitoring to push the boundaries of personalized medicine.

Recurrence Monitoring

Our platform helps monitor Minimum Residual Disease (MRD), leading to early detection of recurrance

Artificial Intelligence (AI) & Machine Learning (ML)

We use Artificial Intelligence and Machine Learning to interpret biomarker signals

Questions?

Page updated

Report abuse